June 2018 ARTICLE LIST >>
PharmaTutor (June - 2018)
ISSN: 2347 - 7881
(Volume 6, Issue 6)
Received On: 28/03/2018; Accepted On: 26/04/2018; Published On: 01/06/2018
AUTHORS:
Vishwas B. Chavan
Aditya Jyot Hospital and Foundation
Mumbai, Maharashtra, India
vishwaschavan2003@yahoo.co.in
ABSTRACT
Cancer is one of the leading causes of morbidity and mortality worldwide. Many patients succumbed to the disease despite best efforts from medical and surgical oncologists. This is because of several challenges like treatment resistance, genetic heterogeneity of tumor cells and high cost of new therapies. It is clear from the recent research that to overcome cancer, a gentler approach is necessary. This approach include controlling inflammatory processes, discovering compounds which can offer minimum resistance from cancer cells, targeting therapy where it is actually needed and increase strength of the patient’s body by non-drug ways like exercise and modulating gut microflora. Scientists can help the patients more directly by devising more clinical level studies and publishing results as much as possible, even negative ones (like failure of a novel drug to treat cancer), to avoid loss of precious time and money. A coordinated effort from clinicians, patients and scientists planning studies at clinical level and publication of data, even negative ones can help defeat cancer, even at advanced metastatic stage IV stage.
How to cite this article: Chavan VB; Cancer Cure: Handle Gently (New hopes for patients and responsibilities of scientists); PharmaTutor; 2018; 6(6); 14-18; http://dx.doi.org/10.29161/PT.v6.i6.2018.14
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. A call for pragmatism in cancer research. Nature Reviews Clinical Oncology 15, 193 (April 2018).
2. Alok A, Singh ID, Singh S. et al. (2017); “Curcumin: Pharmacological actions and its role in head and neck squamous cell carcinoma - A review”; J Indian Acad Oral Med Radiol; 29(2); 115-118.
3. Baker AT (2018); “Engineered Viruses as Precision Cancer Therapeutics”; available at: https://www.labroots.com/webinar/engineered-viruses-precision-cancer-therapeutics, Accessed 08/03/2018).
4. Borsi I, Fasano A, Primicerio M, et al. (2017); “A non-local model for cancer stem cells and the tumour growth paradox”; Math Med Biol.; 34(1); 59-75.
5. Gopalakrishnan V, Spencer CN, Nezi L et al. (2018); “Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients”; Science (New York, NY); 359(6371); 97-103.
6. Housman G, Byler S, Heerboth S, et al. (2014); “Drug Resistance in Cancer: An Overview”; Cancers; 6(3); 1769 -1792.
7. https://en.wikipedia.org/wiki/Metastasis#Pathophysiology (Accessed 08/03/2018)
8. Koelwyn GJ, Quail DF, Zhang X, et al. (2017); “Exercise-dependent regulation of the tumour microenvironment”; Nature Reviews Cancer; 17; 620 - 632.
9. Killing cancer softly: new approach halts tumor growth. (2017) available at: http://www.medicationjunction.com/killing-cancer-softly-new approach-halts-tumor-growth/ (Accessed on 28/03/2018)
10. Megan L. Sulciner, Charles N. Serhan, Molly M. Gilligan et al (2018); “Resolvins suppress tumor growth and enhance cancer therapy”; Journal of Experimental Medicine; 215 (1); 115-140.
11. Naito S, Koga H, Yamaguchi A et al. (2008); “Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer”; J Urol.; 179(2); 485-490.
12. Vogelstein B, Papadopoulos N, Velculescu VE et al. (2013); “Cancer Genome Landscapes”; Science; 339(6127); 1546–1558.
13. Weintraub PG. (2016); “The Importance of Publishing Negative Results”; Journal of Insect Science; 2016; 16(1); 109.
14. WHO Cancer Fact sheet February 2018. Available at: http://www.who.int/mediacentre/factsheets/fs297/en/ (Accessed 08/03/2018)
15. Xuan Pham (2017), “Kill Cancer Gently, Kill Cancer More Completely”, available at: https://www.labroots.com/trending/cancer/7488/kill-cancer-gently-kill-cancer-completely, (Accessed 08/03/2018).
.png)
